GMTX

NASDAQ

Gemini Therapeutics Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical Preparations

$13.50+12.20 (+938.46%)

News25/Ratings7

Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD) and linked ocular disorders. Its lead candidate is GEM103, a recombinant form of the human complement factor H protein that is in a Phase 2a trials in dry AMD patients with a complement factor H protein risk variant. The company was founded in 2015 and is based in Cambridge, Massachusetts.

Latest news

25 items

798dINSIDER
Franchi Jean M. was granted 36,666 shares (SEC Form 4)
4 - Disc Medicine, Inc. (0001816736) (Issuer)
798dINSIDER
SEC Form 3 filed by new insider Franchi Jean M.
3 - Disc Medicine, Inc. (0001816736) (Issuer)
799d13D/G
SEC Form SC 13G/A filed by Gemini Therapeutics Inc. (Amendment)
SC 13G/A - Disc Medicine, Inc. (0001816736) (Subject)
800d13D/G
SEC Form SC 13G/A filed by Gemini Therapeutics Inc. (Amendment)
SC 13G/A - Disc Medicine, Inc. (0001816736) (Subject)
804d13D/G
SEC Form SC 13G/A filed by Gemini Therapeutics Inc. (Amendment)
SC 13G/A - Disc Medicine, Inc. (0001816736) (Subject)
806dSEC
Gemini Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure
8-K - Disc Medicine, Inc. (0001816736) (Filer)
806d13D/G
SEC Form SC 13G/A filed by Gemini Therapeutics Inc. (Amendment)
SC 13G/A - Disc Medicine, Inc. (0001816736) (Subject)
819d13D/G
SEC Form SC 13D/A filed by Gemini Therapeutics Inc. (Amendment)
SC 13D/A - Disc Medicine, Inc. (0001816736) (Subject)
819dINSIDER
Bitterman Kevin sold $6,934,125 worth of shares (102,500 units at $67.65) (SEC Form 4)
4 - Disc Medicine, Inc. (0001816736) (Issuer)
819dINSIDER
Atlas Venture Fund X, L.P. sold $10,147,500 worth of shares (150,000 units at $67.65) (SEC Form 4)
4 - Disc Medicine, Inc. (0001816736) (Issuer)
821dSEC
SEC Form 144 filed by Gemini Therapeutics Inc.
144 - Disc Medicine, Inc. (0001816736) (Subject)
821dSEC
SEC Form 144 filed by Gemini Therapeutics Inc.
144 - Disc Medicine, Inc. (0001816736) (Subject)
832dINSIDER
Bitterman Kevin sold $1,280,000 worth of shares (20,000 units at $64.00) (SEC Form 4)
4 - Disc Medicine, Inc. (0001816736) (Issuer)
832dINSIDER
Atlas Venture Fund X, L.P. sold $3,200,000 worth of shares (50,000 units at $64.00) (SEC Form 4)
4 - Disc Medicine, Inc. (0001816736) (Issuer)
834dSEC
SEC Form 144 filed by Gemini Therapeutics Inc.
144 - Disc Medicine, Inc. (0001816736) (Subject)
834dSEC
SEC Form 144 filed by Gemini Therapeutics Inc.
144 - Disc Medicine, Inc. (0001816736) (Subject)
841dINSIDER
Quisel John D exercised 2,700 shares at a strike of $1.01 (SEC Form 4)
4 - Disc Medicine, Inc. (0001816736) (Issuer)
846dINSIDER
Bryce Joanne exercised 3,000 shares at a strike of $9.86, increasing direct ownership by 120% to 5,500 units (SEC Form 4)
4 - Disc Medicine, Inc. (0001816736) (Issuer)
855dINSIDER
Orbimed Advisors Llc exercised 1,724 shares at a strike of $38.00 and sold $102,130 worth of shares (1,724 units at $59.24) (SEC Form 4)
4 - Disc Medicine, Inc. (0001816736) (Issuer)
855dINSIDER
Ashiya Mona sold $102,130 worth of shares (1,724 units at $59.24) and exercised 1,724 shares at a strike of $38.00 (SEC Form 4)
4 - Disc Medicine, Inc. (0001816736) (Issuer)
860dSEC
SEC Form 144/A filed by Gemini Therapeutics Inc. (Amendment)
144/A - Disc Medicine, Inc. (0001816736) (Subject)
860dSEC
SEC Form 144/A filed by Gemini Therapeutics Inc. (Amendment)
144/A - Disc Medicine, Inc. (0001816736) (Subject)
860dSEC
SEC Form 144/A filed by Gemini Therapeutics Inc. (Amendment)
144/A - Disc Medicine, Inc. (0001816736) (Subject)
860dINSIDER
Ashiya Mona sold $24,584,100 worth of shares (433,200 units at $56.75) (SEC Form 4)
4 - Disc Medicine, Inc. (0001816736) (Issuer)
860dINSIDER
Orbimed Advisors Llc sold $24,584,100 worth of shares (433,200 units at $56.75) (SEC Form 4)
4 - Disc Medicine, Inc. (0001816736) (Issuer)